Clinical Trials

Showing trials with last updates posted in 2026.

NCT06709391 | RECRUITING | NA
90 participants

Fusion or Not - a Study on Low Back Pain

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-31
Start Date:
2025-02-01
Completion:
2030-12-31
Conditions
  • Low Back Pain, Mechanical
  • Degenerative Disc Disease Lumbar
Interventions
  • PROCEDURE
No Results Yet
NCT06649812 | RECRUITING | PHASE2
120 participants

Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-31
Start Date:
2025-10-07
Completion:
2028-09-01
Conditions
  • High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements
  • Recurrent Diffuse Large B-Cell Lymphoma
  • Recurrent Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type
  • Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
  • Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements
  • Recurrent High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements
  • Recurrent High Grade B-Cell Lymphoma, Not Otherwise Specified
  • Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma
  • Refractory Diffuse Large B-Cell Lymphoma
  • Refractory Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type
  • Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
  • Refractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements
  • Refractory High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements
  • Refractory High Grade B-Cell Lymphoma, Not Otherwise Specified
  • Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma
Interventions
  • PROCEDURE
  • DRUG
  • BIOLOGICAL
No Results Yet
NCT06646276 | RECRUITING | PHASE3
530 participants
Previous
Sorted by latest updates
Next
Showing 40 trials per page